Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05657899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The With Or Without Olecranon K-wires Trial

Study acronym: WOW-OK
StatusRecruiting
PhaseNot applicable
Started2023-01-01
View on ClinicalTrials.gov ↗

Amendment history

2026-08-31
minor
3 amendments v2-v4
3 re-verifications since 2024-04-30, no change to tracked fields
2023-01-19
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→2
2022-12-11
minor
Original filing
146 trials monitored
See 5 trials at risk
Fractures of the elbow tip (olecranon) that leave the elbow joint stable but where the fracture ends are separated (Mayo type 2a and 2b) can be treated with pins and a metal wire (tension band wiring, TBW) or metal wiring alone (cerclage fixation, CF ). Previous studies have reported high re-operation and complication rates following TBW. The current study's hypothesis, based on two retrospective studies, is that CF of these fractures yield lower re-operation rates compared with TBW. The investigators also hypothesize that the overall complication rate will be lower following CF. The aim is to investigate this hypothesis in a randomized controlled trial. Patients that are 18 years or older with Mayo type 2a and 2b olecranon fractures at Skåne University hospital will be invited to the study. Participation is voluntary. Patients who accept participation will be randomly assigned to surgery by either TBW or cerclage fixation. Two hundred participants will be followed by physiotherapists for 36 months post-surgery assessing re-operations, complications, patient reported outcome, and elbow function.
Trial Details
NCT Number NCT05657899
Lead Sponsor Region Skane
Collaborators: Lund University
Conditions Olecranon Fracture
Enrollment 200 participants
Start Date 2023-01-01
Primary Completion 2029-09-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-01